Publications

Beicht, J. (2023). Characterization of Langat virus- and vector-based vaccine approaches against tick-borne encephalitis virus. https://nbn-resolving.org/urn:nbn:de:gbv:95-118587
read more

Beicht, J., Kubinski, M., Zdora, I., Puff, C., Biermann, J., Gerlach, T., Baumgärtner, W., Sutter, G., Osterhaus, A., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice. Frontiers in Immunology, 14, Article 1177324. https://doi.org/10.3389/fimmu.2023.1177324
read more

Gonzalez Hernandez, M., Tureli, S., Smith, D. J., van Amerongen, G., Rimmelzwaan, G. F., Pöhlmann, S., Osterhaus, A. D. M., & Steffen, I. (2023). Antigenic distances between emerging SARS-CoV-2 variants of concern. In 32nd Annual Meeting of the Society of Virology: abstracts (P 242).
read more

Kubinski, M., Beicht, J., Zdora, I., Biermann, J., Puff, C., Gerlach, T., Tscherne, A., Baumgärtner, W., Osterhaus, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). A recombinant modified vaccinia virus Ankara expressing prME of tick-borne encephalitis virus affords mice full protection against TBEV infection. Frontiers in Immunology, 14, Article 1182963. https://doi.org/10.3389/fimmu.2023.1182963
read more

Kubinski, M., Beicht, J., Zdora, I., Saletti, G., Kircher, M., Petry-Gusmag, M., Steffen, I., Puff, C., Jung, K., Baumgärtner, W., Rimmelzwaan, G. F., Osterhaus, A. D. M. E., & Prajeeth, C. K. (2023). Cross-reactive antibodies against Langat virus protect mice from lethal tick-borne encephalitis virus infection. Frontiers in Immunology, 14, Article 1134371. https://doi.org/10.3389/fimmu.2023.1134371
read more

Meineke, R., Stelz, S., Busch, M., Werlein, C., Kühnel, M., Jonigk, D., Rimmelzwaan, G. F., & Elbahesh, H. (2023). FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants. iScience, 26(4), Article 106309. https://doi.org/10.1016/j.isci.2023.106309
read more

Nair, N., Osterhaus, A., Rimmelzwaan, G., & Prajeeth, C. K. (2023). Rift Valley fever virus: infection, pathogenesis and host immune responses. Pathogens, 12(9), Article 1174. https://doi.org/10.3390/pathogens12091174
read more

Oosting, S. F., van der Veldt, A. A. M., Fehrmann, R. S. N., Bhattacharya, A., van Binnendijk, R. S., GeurtsvanKessel, C. H., Dingemans, A.-M. C., Smit, E. F., Hiltermann, T. J. N., den Hartog, G., Jalving, M., Westphal, T. T., de Wilt, F., Ernst, S. M., Boerma, A., van Zijl, L., Rimmelzwaan, G. F., Kvistborg, P., van Els, C. A. C. M., et al. (2023). Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors. ESMO Open: Cancer Horizons / European Society for Medical Oncology, 8(4), Article 101599. https://doi.org/10.1016/j.esmoop.2023.101599
read more

Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines, 11(4), Article 714. https://doi.org/10.3390/vaccines11040714
read more

Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient blockade of Type I Interferon signalling promotes replication of Dengue Virus strain D2Y98P in adult wild-type mice. Viruses, 15(4), Article 814. https://doi.org/10.3390/v15040814
read more

Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Recombinant modified vaccinia virus Ankara expressing a glycosylation mutant of dengue virus NS1 induces specific antibody and T-cell responses in mice. Vaccines, 11(4), Article 714. https://doi.org/10.3390/vaccines11040714
read more

Wilken, L., Stelz, S., Prajeeth, C. K., & Rimmelzwaan, G. F. (2023). Transient blockade of Type I Interferon signalling promotes replication of Dengue Virus strain D2Y98P in adult wild-type mice. Viruses, 15(4), Article 814. https://doi.org/10.3390/v15040814
read more

Michaely, L. M., Schuwerk, L., Allnoch, L., Schön, K., Waltl, I., Larsen, P.-K., Pavlou, A., Prajeeth, C. K., Rimmelzwaan, G. F., Becker, S. C., Kalinke, U., Baumgärtner, W., & Gerhauser, I. (2022). Intact type I interferon receptor signaling prevents hepatocellular necrosis but not encephalitis in a dose-dependent manner in Rift Valley fever virus infected mice. International Journal of Molecular Sciences, 23(20), Article 12492. https://doi.org/10.3390/ijms232012492
read more

Petry, M., Palus, M., Leitzen, E., Mitterreiter, J. G., Huang, B., Kröger, A., Verjans, G. M. G. M., Baumgärtner, W., Rimmelzwaan, G. F., Růžek, D., Osterhaus, A., & Prajeeth, C. K. (2021). Immunity to TBEV related flaviviruses with reduced pathogenicity protects mice from disease but not from TBEV entry into the CNS. Vaccines, 9(3: 196). https://doi.org/10.3390/vaccines9030196
read more

Kronenberg, J., Pars, K., Brieskorn, M., Prajeeth, C. K., Heckers, S., Schwenkenbecher, P., Skripuletz, T., Pul, R., Pavlou, A., & Stangel, M. (2019). Fumaric acids directly influence gene expression of neuroprotective factors in rodent microglia. International Journal of Molecular Sciences, 20(2: 325). https://doi.org/10.3390/ijms20020325
read more

Pars, K., Gingele, M., Kronenberg, J., Prajeeth, C. K., Skripuletz, T., Pul, R., Jacobs, R., Gudi, V., & Stangel, M. (2019). Fumaric acids do not directly influence gene expression of neuroprotective factors in highly purified rodent astrocytes. Brain Sciences, 9(9: 241). https://doi.org/10.3390/brainsci9090241
read more

Elbahesh, H., Gerlach, T., Saletti, G., & Rimmelzwaan, G. F. (2019). Response modifiers: tweaking the immune response against influenza A virus. Frontiers in Immunology, 10: 809. https://doi.org/10.3389/fimmu.2019.00809
read more

Elbahesh, H., Saletti, G., Gerlach, T., & Rimmelzwaan, G. F. (2019). Broadly protective influenza vaccines: design and production platforms. Current Opinion in Virology, 34, 1–9. https://doi.org/10.1016/j.coviro.2018.11.005
read more

Gerlach, T., Elbahesh, H., Saletti, G., & Rimmelzwaan, G. F. (2019). Recombinant influenza A viruses as vaccine vectors. Expert Review of Vaccines, 18(4), 379–392. https://doi.org/10.1080/14760584.2019.1582338
read more

Jansen, J. M., Gerlach, T., Elbahesh, H., Rimmelzwaan, G. F., & Saletti, G. (2019). Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination. Journal of Clinical Virology, 119, 44–52. https://doi.org/10.1016/j.jcv.2019.08.009
read more

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). In vitro analysis of specific kinases on Influenza A virus infection. In Stiftung Tierärztliche Hochschule Hannover (Ed.), 12th Graduate School Days: 29/30 November 2019 / Stiftung Tierärztliche Hochschule Hannover. Stiftung Tierärztliche Hochschule Hannover.
read more

Meineke, R., Rimmelzwaan, G. F., & Elbahesh, H. (2019). Influenza virus infections and cellular kinases. Viruses, 11(2: 171). https://doi.org/10.3390/v11020171
read more